Stem Cell Research
This article was originally published in RAJ Devices
New Norwegian law opens door for human embryonic stem cell research
You may also be interested in...
German sickness insurance funds are under unusual financial pressure as a result of the COVID-19 pandemic. And a recent decision to reduce reimbursement for COVID-19 confirmatory tests by one third has left testing labs and diagnostics makers frustrated. See what Martin Walger, chief executive of the German diagnostic industry association (VDGH) said about it here.
US FDA adds brucellosis, opisthorchiasis and paragonimiasis to the list of qualifying diseases but declines to include clonorchiasis and coccidioidomycosis, finding a significant market in developed nations for treatments or vaccines addressing the two conditions.
Mallinckrodt’s Terlipressin Narrowly Clears US FDA Panel As Need For Liver Treatment Outweighs Safety Worries
Advisory committee votes 8-7 to recommend approval for terlipressin to treat HRS-1 but is critical of Mallinckrodt’s plan to mitigate the risk of respiratory failure.